{"transactions":[{"id":2087476,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":121651,"kind":"person","name":"FLESHER GREGORY J.","position":1,"cik":"0001705287","reported_name":"FLESHER GREGORY J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock option (right to buy)","published_at":"2022-12-13T23:09:05.000Z","date":"2022-12-09","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vest in a series of 16 equal quarterly installments measured from December 9, 2022 subject to Reporting Person's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) as of each such vesting date."}],"balance_after":300000,"derivative":{"exercise_price":1.8,"expiration_date":"2032-12-08","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001209191-22-061034","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1637715/000120919122061034/doc4.xml","form_type":"4"}},{"id":2472895,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":121651,"kind":"person","name":"FLESHER GREGORY J.","position":1,"cik":"0001705287","reported_name":"FLESHER GREGORY J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock option (right to buy)","published_at":"2021-12-14T21:31:03.000Z","date":"2021-12-10","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares vest in a series of 48 successive equal monthly installments measured from December 10, 2021, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) as of each such vesting date."}],"balance_after":200000,"derivative":{"exercise_price":6.69,"expiration_date":"2031-12-09","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-21-069443","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1637715/000120919121069443/doc4.xml","form_type":"4"}},{"id":2472894,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":121651,"kind":"person","name":"FLESHER GREGORY J.","position":1,"cik":"0001705287","reported_name":"FLESHER GREGORY J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-12-14T21:31:03.000Z","date":"2021-12-10","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,600 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan on December 8, 2021."}],"balance_after":109600,"source":{"system":"sec-edgar","filing":"0001209191-21-069443","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1637715/000120919121069443/doc4.xml","form_type":"4"}},{"id":2589238,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":121651,"kind":"person","name":"FLESHER GREGORY J.","position":1,"cik":"0001705287","reported_name":"FLESHER GREGORY J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-08-26T21:52:56.000Z","date":"2021-08-25","kind":"purchase","acquired":true,"shares":8000,"price":8,"value":64000.0,"ownership":{"direct":true},"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001209191-21-053522","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1637715/000120919121053522/doc4.xml","form_type":"4"}},{"id":3199215,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":121651,"kind":"person","name":"FLESHER GREGORY J.","position":1,"cik":"0001705287","reported_name":"FLESHER GREGORY J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-20T20:31:53.000Z","date":"2020-03-19","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 200,000 shares of the Issuer's Common Stock, one quarter of which will become fully vested and exercisable on March 19, 2021, with the remaining 150,000 shares vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":200000,"derivative":{"exercise_price":0.26,"expiration_date":"2030-03-19","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000899243-20-009126","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000089924320009126/doc4.xml","form_type":"4"}},{"id":3404351,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":121651,"kind":"person","name":"FLESHER GREGORY J.","position":1,"cik":"0001705287","reported_name":"FLESHER GREGORY J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-01T01:30:19.000Z","date":"2019-09-26","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 100,000 shares of the Issuer's Common Stock, which will vest in equal installments on the first and second anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":100000,"derivative":{"exercise_price":0.67,"expiration_date":"2029-09-26","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-19-024431","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000089924319024431/doc4.xml","form_type":"4"}},{"id":3515039,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":121651,"kind":"person","name":"FLESHER GREGORY J.","position":1,"cik":"0001705287","reported_name":"FLESHER GREGORY J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-05-22T20:01:58.000Z","date":"2019-05-21","kind":"sale","acquired":false,"shares":2937,"price":1.9114,"value":5613.7818,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were sold to cover the reporting person's taxes due on the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $1.90 to $1.945. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":156918,"source":{"system":"sec-edgar","filing":"0001562180-19-003051","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000156218019003051/primarydocument.xml","form_type":"4"}},{"id":3515038,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":121651,"kind":"person","name":"FLESHER GREGORY J.","position":1,"cik":"0001705287","reported_name":"FLESHER GREGORY J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-05-22T20:01:58.000Z","date":"2019-05-20","kind":"sale","acquired":false,"shares":11701,"price":1.9616,"value":22952.6816,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were sold to cover the reporting person's taxes due on the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $1.90 to $2.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":159855,"source":{"system":"sec-edgar","filing":"0001562180-19-003051","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000156218019003051/primarydocument.xml","form_type":"4"}},{"id":3590349,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":121651,"kind":"person","name":"FLESHER GREGORY J.","position":1,"cik":"0001705287","reported_name":"FLESHER GREGORY J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-18T20:23:56.000Z","date":"2019-03-14","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 90,000 shares of the Issuer's Common Stock, which will vest in equal quarterly installments through the fourth anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":90000,"derivative":{"exercise_price":3.72,"expiration_date":"2029-03-14","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0000899243-19-008140","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000089924319008140/doc4.xml","form_type":"4"}},{"id":3590348,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":121651,"kind":"person","name":"FLESHER GREGORY J.","position":1,"cik":"0001705287","reported_name":"FLESHER GREGORY J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-03-18T20:23:56.000Z","date":"2019-03-14","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This represents restricted stock units representing the right to receive shares of the Issuer's Common Stock, which will vest in full on the later of achievement of a performance-related goal or the first anniversary of the grant date."}],"balance_after":171556,"source":{"system":"sec-edgar","filing":"0000899243-19-008140","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000089924319008140/doc4.xml","form_type":"4"}},{"id":3994495,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":121651,"kind":"person","name":"FLESHER GREGORY J.","position":1,"cik":"0001705287","reported_name":"FLESHER GREGORY J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-15T22:51:18.000Z","date":"2018-03-13","kind":"grant","acquired":true,"shares":56500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 56,500 shares of the Issuer's Common Stock, one quarter of which will become fully vested and exercisable on March 13, 2019, with the remaining 42,375 shares vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":56500,"derivative":{"exercise_price":4.83,"expiration_date":"2028-03-13","underlying":"Common Stock","underlying_shares":56500},"source":{"system":"sec-edgar","filing":"0000899243-18-007647","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000089924318007647/doc4.xml","form_type":"4"}},{"id":3994494,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":121651,"kind":"person","name":"FLESHER GREGORY J.","position":1,"cik":"0001705287","reported_name":"FLESHER GREGORY J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-03-15T22:51:18.000Z","date":"2018-03-13","kind":"grant","acquired":true,"shares":30700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This represents restricted stock units representing the right to receive shares of the Issuer's Common Stock, which will vest in full on the later of achievement of a performance-related goal or the first anniversary of the grant date."}],"balance_after":146556,"source":{"system":"sec-edgar","filing":"0000899243-18-007647","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000089924318007647/doc4.xml","form_type":"4"}},{"id":4302865,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":121651,"kind":"person","name":"FLESHER GREGORY J.","position":1,"cik":"0001705287","reported_name":"FLESHER GREGORY J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-26T20:06:33.000Z","date":"2017-05-24","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 250,000 shares of the Issuer's Common Stock. 150,000 shares will vest ratably each month over three years beginning on May 24, 2017 (the \"grant date\"). 100,000 shares will vest on the later of achievement of a performance-related goal or the first anniversary of the grant date."}],"balance_after":250000,"derivative":{"exercise_price":5.5,"expiration_date":"2027-05-23","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0000899243-17-014542","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000089924317014542/doc4.xml","form_type":"4"}},{"id":4324528,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":121651,"kind":"person","name":"FLESHER GREGORY J.","position":1,"cik":"0001705287","reported_name":"FLESHER GREGORY J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-05-12T00:36:06.000Z","date":"2017-05-10","kind":"purchase","acquired":true,"shares":58959,"price":9.99,"value":589000.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All numbers give effect to the 1:9 reverse stock split effected by the Issuer on May 11, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"All numbers give effect to the 1:9 reverse stock split effected by the Issuer on May 11, 2017."}],"balance_after":115856,"source":{"system":"sec-edgar","filing":"0000899243-17-012936","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000089924317012936/doc4.xml","form_type":"4"}}]}